About Talphera, Inc.
https://talphera.comTalphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.
CEO
Vincent J. Angotti
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-10-26 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
AIGH CAPITAL MANAGEMENT LLC
Shares:4.45M
Value:$4.63M
ROSALIND ADVISORS, INC.
Shares:4.39M
Value:$4.56M
ROCK SPRINGS CAPITAL MANAGEMENT LP
Shares:3.59M
Value:$3.73M
Summary
Showing Top 3 of 37
About Talphera, Inc.
https://talphera.comTalphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1K ▲ | $3.42M ▼ | $-4.44M ▼ | -443.6K% ▼ | $-0.11 ▼ | $-4.44M ▼ |
| Q2-2025 | $0 ▼ | $3.69M ▲ | $-3.49M ▼ | 0% ▲ | $-0.1 ▼ | $-3.49M ▼ |
| Q1-2025 | $27K ▲ | $1.77M ▲ | $-2.59M ▼ | -9.6K% ▼ | $-0.1 ▼ | $0 ▲ |
| Q4-2024 | $0 | $1.67M ▼ | $-1.87M ▲ | 0% | $-0.07 ▲ | $-2.97M ▲ |
| Q3-2024 | $0 | $1.7M | $-3.35M | 0% | $-0.13 | $-3.73M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $21.29M ▲ | $30.74M ▲ | $11.56M ▲ | $19.18M ▲ |
| Q2-2025 | $6.79M ▲ | $16.52M ▲ | $9.89M ▲ | $6.63M ▲ |
| Q1-2025 | $5.39M ▼ | $14.99M ▼ | $9.4M ▼ | $5.6M ▼ |
| Q4-2024 | $8.86M ▼ | $18.24M ▼ | $10.24M ▼ | $8M ▼ |
| Q3-2024 | $11.12M | $21.01M | $11.37M | $9.64M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-4.44M ▼ | $-2.51M ▲ | $-17.82M ▼ | $16.99M ▲ | $-3.33M ▼ | $-2.51M ▲ |
| Q2-2025 | $-3.49M ▼ | $-2.95M ▲ | $0 | $4.35M ▲ | $1.4M ▲ | $-2.95M ▲ |
| Q1-2025 | $-2.67M ▼ | $-3.47M ▼ | $0 | $-5K ▼ | $-3.48M ▼ | $-3.47M ▼ |
| Q4-2024 | $-1.87M ▲ | $-2.25M ▲ | $0 ▼ | $0 ▼ | $-2.25M ▲ | $-2.25M ▲ |
| Q3-2024 | $-3.35M | $-2.94M | $600K | $30K | $-2.31M | $-2.94M |
CEO
Vincent J. Angotti
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-10-26 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
AIGH CAPITAL MANAGEMENT LLC
Shares:4.45M
Value:$4.63M
ROSALIND ADVISORS, INC.
Shares:4.39M
Value:$4.56M
ROCK SPRINGS CAPITAL MANAGEMENT LP
Shares:3.59M
Value:$3.73M
Summary
Showing Top 3 of 37